CLEARPOINT NEURO INC Share Price Today: Live Updates & Key Insights

CLEARPOINT NEURO INC share price today is $9.4, up -1.63%. The stock opened at $9.15 against the previous close of $9.18, with an intraday high of $9.56 and low of $8.93.

CLEARPOINT NEURO INC Share Price Chart

CLEARPOINT NEURO INC

us-stock
To Invest in {{usstockname}}
us-stock

CLEARPOINT NEURO INC Share Price Performance

$9.4 -0.0163(-1.63%) CLPT at 23 Mar 2026 12:29 PM Medical Devices
Lowest Today 8.93
Highest Today 9.56
Today’s Open 9.15
Prev. Close 9.18
52 Week High 30.10
52 Week Low 8.63
Day’s Range: Low 8.93 High 9.56
52-Week Range: Low 8.63 High 30.10
1 day return -
1 Week return -18.69
1 month return -38.98
3 month return -38.52
6 month return -25.49
1 year return -34.64
3 year return +11.94
5 year return -60.33
10 year return -

CLEARPOINT NEURO INC Institutional Holdings

BlackRock Inc 6.26

Vanguard Group Inc 5.94

Vanguard Total Stock Mkt Idx Inv 2.98

Geode Capital Management, LLC 2.20

iShares Russell 2000 ETF 2.17

Millennium Management LLC 1.73

Rolnik Focus FIL 1.68

State Street Corp 1.62

StemPoint Capital LP 1.62

FirstWave Capital Management LLC 1.22

UBS Group AG 1.21

Brown Advisory Holdings Inc 1.11

Lane Generational LLC 1.05

Vanguard Institutional Extnd Mkt Idx Tr 1.04

Fidelity Small Cap Index 0.87

Morgan Stanley - Brokerage Accounts 0.79

Deutsche Bank AG 0.78

iShares Russell 2000 Growth ETF 0.75

Two Sigma Investments LLC 0.74

Balyasny Asset Management LLC 0.73

Northern Trust Corp 0.69

Vanguard Explorer Inv 0.51

Fidelity Extended Market Index 0.51

Susquehanna International Group, LLP 0.51

Parsons Capital Management Inc 0.49

State St Russell Sm/Mid Cp® Indx SL Cl I 0.47

Taylor Frigon Capital Management LLC 0.45

Conway Capital Management Inc 0.43

Vanguard Russell 2000 ETF 0.42

DWS Small Cap Core S 0.41

Small Cap Core Equity Composite 0.41

The Colony Group LLC 0.41

Stt Strt® SPDR® S&P®HlthCrEqpmntETF 0.36

State St Russell Sm Cap® Indx SL Cl I 0.31

Blackrock Extended Mkt Fund CF 0.25

iShares Micro-Cap ETF 0.23

Schwab Small Cap Index 0.22

Extended Equity Market Fund K 0.21

NT R2000 Index Fund - NL 0.20

DWS Global Small Cap S 0.20

CLEARPOINT NEURO INC Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

CLEARPOINT NEURO INC Fundamentals

Market Cap 268.63 M

PB Ratio 17.2036

PE Ratio 0.0

Enterprise Value 270.61 M

Total Assets 97.75 M

Volume 1279560

CLEARPOINT NEURO INC Company Financials

Annual Revenue FY24:31390000 31.4M, FY23:22319000 22.3M, FY22:20551000 20.6M, FY21:16299000 16.3M, FY20:12829000 12.8M

Annual Profit FY24:19122000 19.1M, FY23:12967000 13.0M, FY22:13531000 13.5M, FY21:11291000 11.3M, FY20:9120000 9.1M

Annual Net worth FY24:-18914000 -18.9M, FY23:-21855000 -21.9M, FY22:-16538000 -16.5M, FY21:-15320000 -15.3M, FY20:-9108000 -9.1M

Quarterly Revenue Q3/2025:8861000 8.9M, Q2/2025:9215000 9.2M, Q1/2025:8485000 8.5M, Q3/2024:8122000 8.1M, Q2/2024:7858000 7.9M

Quarterly Profit Q3/2025:5600000 5.6M, Q2/2025:5556000 5.6M, Q1/2025:5132000 5.1M, Q3/2024:4847000 4.8M, Q2/2024:4988000 5.0M

Quarterly Net worth Q3/2025:-5891000 -5.9M, Q2/2025:-5837000 -5.8M, Q1/2025:-6026000 -6.0M, Q3/2024:-4974000 -5.0M, Q2/2024:-4408000 -4.4M

About CLEARPOINT NEURO INC & investment objective

Company Information ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Organisation Medical Devices

Employees 172

Industry Medical Devices

CEO Mr. Joseph Michael Burnett

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CLEARPOINT NEURO INC FAQs

What is the share price of CLEARPOINT NEURO INC today?

The current share price of CLEARPOINT NEURO INC is $9.4.

Can I buy CLEARPOINT NEURO INC shares in India?

Yes, Indian investors can buy CLEARPOINT NEURO INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy CLEARPOINT NEURO INC shares in India?

You can easily invest in CLEARPOINT NEURO INC shares from India by:

Can I buy fractional shares of CLEARPOINT NEURO INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CLEARPOINT NEURO INC?

CLEARPOINT NEURO INC has a market cap of $268.63 M.

In which sector does CLEARPOINT NEURO INC belong?

CLEARPOINT NEURO INC operates in the Medical Devices sector.

What documents are required to invest in CLEARPOINT NEURO INC stocks?

To invest, you typically need:

What is the PE and PB ratio of CLEARPOINT NEURO INC?

The PE ratio of CLEARPOINT NEURO INC is N/A and the PB ratio is 17.20.